Latest News on NAGE

Financial News Based On Company


Advertisement
Advertisement

Niagen Bioscience ( NAGE ) Q2 Earnings and Revenues Surpass Estimates

https://www.zacks.com/stock/news/2675123/niagen-bioscience-nage-q2-earnings-and-revenues-surpass-estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +100.00% and +8.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Niagen NAGE Q2 2025 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2025/08/06/niagen-nage-q2-2025-earnings-call-transcript/
Image source: The Motley Fool.Aug. 6, 2025, 8:30 p.m. ETChief Executive Officer - Rob FriedContinue reading ...

Major Update: Frank Jaksch Jr At Niagen Bioscience Exercises Options, Realizing $0 - Niagen Bioscience ( NASDAQ:NAGE )

https://www.benzinga.com/insights/news/25/06/46118162/major-update-frank-jaksch-jr-at-niagen-bioscience-exercises-options-realizing-0
Frank Jaksch Jr, Board Member at Niagen Bioscience NAGE, reported a large exercise of company stock options on June 26, according to a new SEC filing. What Happened: In an insider options sale disclosed in a Form 4 filing on Thursday with the U.S.

Options Exercise Update At Niagen Bioscience: Ann Cohen Engages, Resulting In $0 - Niagen Bioscience ( NASDAQ:NAGE )

https://www.benzinga.com/insights/news/25/06/46118160/options-exercise-update-at-niagen-bioscience-ann-cohen-engages-resulting-in-0
In a new SEC filing on June 26, it was revealed that Cohen, Director at Niagen Bioscience NAGE, executed a significant exercise of company stock options. What Happened: A Form 4 filing from the U.S.

Options Exercise Update At Niagen Bioscience: Jeong James Lee Attorney-in-Fact Engages, Resulting In $0 - Niagen Bioscience ( NASDAQ:NAGE )

https://www.benzinga.com/insights/news/25/06/46118156/options-exercise-update-at-niagen-bioscience-jeong-james-lee-attorney-in-fact-engages-resulting-in-
A large exercise of company stock options by Jeong James Lee Attorney-in-Fact, Board Member at Niagen Bioscience NAGE was disclosed in a new SEC filing on June 26, as part of an insider exercise. What Happened: A Form 4 filing from the U.S.
Advertisement

Steven Rubin At Niagen Bioscience Exercises Options Worth $0 - Niagen Bioscience ( NASDAQ:NAGE )

https://www.benzinga.com/insights/news/25/06/46118154/steven-rubin-at-niagen-bioscience-exercises-options-worth-0
On June 26, it was revealed in an SEC filing that Steven Rubin, Director at Niagen Bioscience NAGE executed a significant exercise of company stock options. What Happened: Rubin, Director at Niagen Bioscience, made a strategic move by exercising stock options for 0 shares of NAGE as detailed in a ...

Niagen Bioscience ( NAGE ) Q1 Earnings and Revenues Beat Estimates

https://www.zacks.com/stock/news/2464574/niagen-bioscience-nage-q1-earnings-and-revenues-beat-estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of 100% and 13.10%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Robert Fried Exercises Options, Realizes $173K - Niagen Bioscience ( NASDAQ:NAGE )

https://www.benzinga.com/insights/news/25/04/44739279/robert-fried-exercises-options-realizes-173k
A large exercise of company stock options by Robert Fried, Chief Executive Officer at Niagen Bioscience NAGE was disclosed in a new SEC filing on April 9, as part of an insider exercise. What Happened: A Form 4 filing from the U.S.
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion